Psychostimulants in supportive care

Support Care Cancer. 2000 Sep;8(5):385-97. doi: 10.1007/s005200050007.

Abstract

Psychostimulant medications have been used clinically and investigated in psychiatric populations, the medically ill, cancer patients and healthy people. This article discusses the pharmacology of dextroamphetamine, methylphenidate, pemoline (and other psychostimulants such as caffeine and ephedrine), their use in general medicine and cancer care, side effects, and abuse potential. Therapeutic use in children is addressed only insofar as it illustrates facets of their use in adults.

Publication types

  • Review

MeSH terms

  • Adult
  • Caffeine / adverse effects
  • Caffeine / pharmacology
  • Caffeine / therapeutic use
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / pharmacology
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Dextroamphetamine / adverse effects
  • Dextroamphetamine / pharmacology
  • Dextroamphetamine / therapeutic use*
  • Ephedrine / adverse effects
  • Ephedrine / pharmacology
  • Ephedrine / therapeutic use
  • Humans
  • Mental Disorders / drug therapy
  • Mental Disorders / etiology
  • Methylphenidate / adverse effects
  • Methylphenidate / pharmacology
  • Methylphenidate / therapeutic use*
  • Neoplasms / complications*
  • Neoplasms / psychology*
  • Pemoline / adverse effects
  • Pemoline / pharmacology
  • Pemoline / therapeutic use*
  • Substance-Related Disorders

Substances

  • Central Nervous System Stimulants
  • Methylphenidate
  • Caffeine
  • Pemoline
  • Ephedrine
  • Dextroamphetamine